Search results
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 44 minutes agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 5 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 2 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 4 days agoInvestors can capitalize on this by...Zacks Consensus EPS estimate has moved 0.23% lower. AbbVie is...
AbbVie (ABBV) Could Be a Great Choice
Zacks· 4 days agoWhile cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out ...
AbbVie Inc. (NYSE:ABBV) Receives $176.14 Average PT from Brokerages
ETF DAILY NEWS· 3 days agoBMO Capital Markets decreased their target price on AbbVie from $195.00 to $180.00 and set an “outperform” rating on the stock in a report ...
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 4 days agoAbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...
Why Investors Are Eyeing AbbVie Inc (ABBV): The Key Drivers of M
Guru Focus· 4 days agoAbbVie Inc (ABBV, Financial) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial performance and promising growth ...
Hedge Fund Favorites: 7 Stocks to Buy When You're Feeling Jittery
InvestorPlace· 1 day agoWith the market entering a historically challenging season (due to the adage buy in May and go...
Oppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating By Investing.com
Investing.com· 1 day agoOppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating